Acupuncture for Treating Attention Deficit Hyperactivity Disorder in Children: A Systematic Review and Meta-Analysis
Ang et al. · Medicina · 2023
OBJECTIVE
Evaluate the efficacy of acupuncture in the treatment of ADHD in children
WHO
Children with ADHD younger than 18 years
DURATION
4-24 weeks of treatment
POINTS
GV-20, SP-6, EM1, PC-6, HT-7, KI-3, LR-3
🔬 Study Design
Acupuncture
n=593
Manual acupuncture or electroacupuncture
Control
n=592
Conventional medication or sham
📊 Results in numbers
Improvement in hyperactivity
Improvement in impulsivity
Overall treatment efficacy
Learning problems
Conduct problems
📊 Outcome Comparison
Hyperactivity-Impulsivity
This study analyzed 14 trials with more than a thousand children with ADHD to determine whether acupuncture may help. The results suggest that acupuncture may improve some symptoms such as hyperactivity and learning problems, but the quality of the evidence remains limited for making definitive recommendations.
Article summary
Plain-language narrative summary
Attention Deficit Hyperactivity Disorder (ADHD) represents one of the most frequent neurological problems in childhood, characterized by persistent patterns of inattention, hyperactivity, and impulsivity that can significantly interfere with children's development and functioning. Although there is no single known cause or definitive cure for ADHD, several treatments have proven effective at reducing symptoms and improving patients' quality of life. Among the therapeutic options, the combination of medication with behavioral therapy has demonstrated the best results. In this context, acupuncture has emerged as a promising complementary alternative, considered relatively safe, accessible, and easy to apply compared with other conventional procedures.
This systematic review aimed primarily to evaluate the efficacy of acupuncture in the treatment of children with ADHD, providing updated evidence on its benefits. The investigators conducted a comprehensive search of nine scientific databases, from inception through July 2022, including both international and Asian databases. Only randomized controlled clinical trials comparing acupuncture with conventional medications, sham acupuncture, or waitlist were selected. Inclusion criteria covered children younger than 18 years diagnosed with ADHD, regardless of sex or nationality.
Study quality was rigorously evaluated using standardized tools, and results were analyzed statistically through meta-analysis when appropriate.
The results of this investigation were based on fourteen studies involving 1,185 children with ADHD, primarily conducted in China, Korea, and Iran. The analysis revealed encouraging findings regarding the effects of acupuncture. When used as an adjunct to conventional drug treatment, acupuncture demonstrated significant positive effects in reducing conduct problems, learning difficulties, hyperactivity, and impulsivity compared with medication alone. Similarly, acupuncture applied as monotherapy also proved superior to conventional medications on several measures, including improvement in learning problems, reduction in hyperactivity and impulsivity, and greater overall treatment efficacy.
Notably, the studies reported no serious adverse events related to the procedure, suggesting a favorable safety profile.
The clinical implications of these findings are potentially important for both healthcare professionals and patients and families. Acupuncture may represent a valuable therapeutic option, especially when integrated with conventional treatment, offering additional benefits in improving ADHD symptoms. For clinicians, these results suggest that acupuncture could be considered as part of an integrated therapeutic approach, particularly for families seeking alternatives or complements to traditional pharmacologic treatments. For patients and their families, acupuncture offers a relatively safe option that may aid in symptom control, especially those related to behavior and learning.
However, it is essential to recognize the significant limitations of this study. The methodologic quality of the included trials was considered concerning, with important deficiencies in randomization, blinding, and follow-up of participants. Many studies did not provide adequate information on how participants were allocated to groups or how allocation concealment was maintained. In addition, most studies did not adequately assess adverse effects of treatment, and there was inconsistency in the scales used to measure ADHD symptoms, limiting comparison across studies.
The investigators emphasize that, despite the promising results, current evidence remains insufficient to recommend routine use of acupuncture in the treatment of ADHD. Future investigations with more rigorous methodology, larger samples, better control of variables, and long-term follow-up are needed to definitively validate the efficacy and safety of this intervention in children with ADHD.
Strengths
- 1Comprehensive meta-analysis of 14 studies
- 2Analysis of multiple ADHD domains
- 3Safety assessment included
- 4Search across multiple databases
Limitations
- 1Concerning methodologic quality of the studies
- 2Lack of adequate blinding
- 3Heterogeneous assessment instruments
- 4Insufficient evidence for recommendations
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
ADHD is among the most prevalent neuropsychiatric conditions of childhood, and the search for strategies complementary to methylphenidate and behavioral interventions is a recurring theme in pediatric outpatient practice. This meta-analysis, gathering 1,185 children across 14 randomized trials, offers the clinician treating this population a quantitative reference point for discussions with families who resist or do not tolerate conventional pharmacotherapy. The effect sizes observed for hyperactivity (SMD -1.43) and conduct problems (MD -1.35) are clinically meaningful and position acupuncture, especially when combined with medication, as a plausible adjunct in children whose symptom control remains partial. Families culturally receptive to integrative medicine, children with unsatisfactory response to stimulants, or those with unacceptable adverse effects represent the scenario in which this evidence finds immediate applicability within a structured treatment plan.
▸ Notable Findings
The most striking finding is not the efficacy of acupuncture in isolation but its capacity to potentiate drug treatment: when used as an adjunct, benefits in conduct, learning, hyperactivity, and impulsivity exceeded those obtained with medication alone across all metrics analyzed. Another noteworthy point is the breadth of the domains affected; the effect was not restricted to motor hyperactivity but extended to learning problems (MD -1.04) and conduct (MD -1.35), dimensions that typically respond less to pharmacologic interventions alone. The absence of serious adverse events across the entire set of studies is relevant information for risk-benefit reasoning, particularly in a pediatric population where treatment tolerability is decisive for long-term family adherence.
▸ From My Experience
In my practice with children referred to the service after partial response to pharmacotherapy, I have observed that acupuncture works best as part of a triad that includes medication adjusted by the pediatric neurologist and structured behavioral intervention — rarely as monotherapy. I usually start with weekly sessions, and in general families begin to report improvement in agitation and sleep quality after four to six sessions; teachers, who often fill out follow-up scales, perceive behavioral changes somewhat later, around the eighth session. For maintenance, we customarily reach a cycle of twelve sessions, followed by reassessment. The patient profile that responds best, in my experience, is the child with hyperactive-impulsive predominance, between six and ten years of age, whose parents are adherent and understand that results are cumulative. I do not recommend acupuncture as the sole resource in severe cases with marked school impairment — in these cases, optimized pharmacotherapy has absolute priority before any integration.
Full original article
Read the full scientific study
Medicina · 2023
DOI: 10.3390/medicina59020392
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories